Contrast Agents for MR Imaging

被引：12

作者：

Czeyda-Pommersheim, Ferenc ^{[1
]}

Martin, Diego R. ^{[1
]}

Costello, James R. ^{[1
]}

Kalb, Bobby ^{[1
]}

机构：

[1] Univ Arizona, Dept Med Imaging, 1501 N Campbell Ave,POB 245067, Tucson, AZ 85724 USA

来源：

MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA | 2017年 / 25卷 / 04期

关键词：

Radiographic contrast; Contrast-enhanced MR imaging; Gadolinium-based MR imaging contrast; Manganese-based MR imaging contrast; Iron-based MR imaging contrast; Contrast-related adverse events; NEPHROGENIC SYSTEMIC FIBROSIS; GADOPENTETATE DIMEGLUMINE; GADOLINIUM DEPOSITION; RENAL-INSUFFICIENCY; ADVERSE-REACTIONS; ENHANCED MRI; MEDIA; GADODIAMIDE; SAFETY; LIVER;

D O I：

10.1016/j.mric.2017.06.011

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Contrast media are essential to the practice of MR imaging. An increasing variety of agents have been approved for clinical use, and specific contrast agents can often be tailored to a specific clinical question. Compared with computed tomography contrast media, MR imaging contrast is well tolerated with an excellent safety record and a low incidence of adverse events. In this article, we review the pharmacology, indications, and the common adverse events of the intravenous and oral MR contrast agents most commonly used in contemporary imaging practice, including gadolinium-based contrast, manganese and iron-based agents, and the most common oral contrast agents.

引用

页码：705 / +

页数：8

共 43 条

[1] Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model [J].

Adzamli, K ;

Yablonskiy, DA ;

Chicoine, MR ;

Won, EK ;

Galen, KP ;

Zahner, MC ;

Woolsey, TA ;

Ackerman, JJH .

MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) :586-590

[2] Biodistribution of Gadolinium-Based Contrast Agents, Including Gadolinium Deposition [J].

Aime, Silvio ;

Caravan, Peter .

JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) :1259-1267

[3] Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy-Report from Two US Universities [J].

Altun, Ersan ;

Martin, Diego R. ;

Wertman, Rebecca ;

Lugo-Somolinos, Aida ;

Fuller, Edwin R., III ;

Semelka, Richard C. .

RADIOLOGY, 2009, 253 (03) :689-696

[4] Extracellular gadolinium-based contrast media: An overview [J].

Bellin, Marie-France ;

Van Der Molen, Aart J. .

EUROPEAN JOURNAL OF RADIOLOGY, 2008, 66 (02) :160-167

[5] Gadolinium deposition in nephrogenic fibrosing dermopathy [J].

Boyd, Alan S. ;

Zic, John A. ;

Abraham, Jerrold L. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) :27-30

[6] Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].

Caravan, P ;

Ellison, JJ ;

McMurry, TJ ;

Lauffer, RB .

CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352

[7] Nephrogenic fibrosing dermopathy [J].

Cowper, SE ;

Su, LD ;

Bhawan, J ;

Robin, HS ;

LeBoit, PE .

AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2001, 23 (05) :383-393

[8]

Finn JP, 2017, J MAGN RESON IMAGING

[9] MR contrast agents for liver imaging: What, when, how [J].

Gandhi, Sunil N. ;

Brown, Michele A. ;

Wong, James G. ;

Aguirre, Diego A. ;

Sirlin, Claude B. .

RADIOGRAPHICS, 2006, 26 (06) :1621-1636

[10] Oral contrast agents in MRI of the gastrointestinal tract [J].

Giovagnoni, A ;

Fabbri, A ;

Maccioni, F .

ABDOMINAL IMAGING, 2002, 27 (04) :367-375

← 1 2 3 4 5 →